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ABSTRACT
Purpose The aim of this study was to develop a method to
characterize intact soluble monoclonal IgG1 antibody (IgG)
oligomers by mass spectrometry.
Methods IgG aggregates (dimers, trimers, tetramers and high-
molecular-weight oligomers) were created by subjecting an
IgG formulation to several pH jumps. Protein oligomer
fractions were isolated by high performance size exclusion
chromatography (HP-SEC), dialyzed against ammonium acetate
pH 6.0 (a mass spectrometry-compatible volatile buffer), and
analyzed by native electrospray ionization time-of-flight mass
spectrometry (ESI-TOF MS).
Results Monomeric and aggregated IgG fractions in the
stressed IgG formulation were successfully isolated by HP-
SEC. ESI-TOF MS analysis enabled us to determine the
molecular weight of the monomeric IgG as well as the
aggregates, including dimers, trimers and tetramers. HP-SEC
separation and sample preparation proved to be necessary for
good quality signal in ESI-TOF MS. Both the HP-SEC protocol
and the ESI-TOF mass spectrometric technique were shown to
leave the IgG oligomers largely intact.
Conclusions ESI-TOF MS is a useful tool complementary to
HP-SEC to identify and characterize small oligomeric protein
aggregates.
KEY WORDS HP-SEC . IgG1 . monoclonal antibody .
native ESI-TOF mass spectrometry . protein aggregation
INTRODUCTION
Monoclonal antibodies (mAb), also known as immunoglo-
bulins (Ig), are glycoproteins used as therapeutics for the
treatment of several life-threatening conditions, including
cancer, inflammatory diseases, complications upon organ
transplantation, and infectious and cardiovascular diseases
(1–3). Among the five different classes of Ig, IgG is the
most abundant one and widely used for therapeutic
purposes. The IgG class is further divided into several
subclasses—IgG1, IgG2, IgG3, and IgG4 (in order of
relative abundance in human plasma). The structural
differences among these subtypes are the number and
location of inter-chain disulfide bonds and the length of
the hinge region (3).
Like all other protein therapeutics, mAb can undergo
various degradation processes during production, storage,
transport, etc. (4). Aggregation is a common degradation
process for therapeutic proteins and can occur during
production, formulation and storage (5), e.g. due to pH
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changes, temperature variations and agitation (6–8). Partial
unfolding or other types of conformational changes in the
protein structure may cause aggregate formation (9–12).
Aggregation of therapeutic proteins is highly undesired
since it can lead to activity loss, decreased solubility, and
enhanced unwanted immunogenicity (13–15). Therefore,
there is a great interest in unraveling aggregation pathways
and analyzing the quantity and characteristics of protein
aggregates.
Aggregation of mAbs due to various types of stress
factors has been studied extensively (3,6–8,11,14,16–18).
Structural characterization of mAb aggregates involves
multiple complementary techniques. High performance
size-exclusion chromatography (HP-SEC) is commonly
used for measuring and separating protein aggregates
according to their size (19,20). However, for the identifica-
tion of these separated compounds, other analytical
techniques are required (17,21,22) Molecular weight
determination is a common way in the identification and
characterization of oligomeric mAb species. For this
purpose, sodium dodecyl sulfate/polyacrylamide gel elec-
trophoresis (SDS-PAGE) and on-line multi-angle laser light
scattering detection are accepted techniques; however, both
methods suffer from relatively low mass accuracy and
precision. These limitations can be overcome by using mass
spectrometry (MS), especially electrospray ionization time-
of-flight mass spectrometry (ESI-TOF MS), a method that
can accurately assign the molecular mass of proteins and
aggregates thereof. Specifically, native ESI-TOF MS is
particularly useful for structural characterization of intact
protein aggregates due to the ability of preserving quater-
nary protein structures, maintaining non-covalent protein
interactions and its theoretically unlimited mass range
(23–25).
Native MS combines the advantages of ESI by replacing
the commonly used volatile polar solvents (e.g. water,
acetonitrile, methanol, etc.) with the MS-compatible volatile
aqueous buffer solutions like ammonium acetate (26–29).
With native MS, not only the mass of large protein
complexes, such as ribosomes and whole viruses, can be
determined (30), but also information on their structure,
topology and architecture can be obtained (26,31). Al-
though native MS does not provide detailed molecular
structure information, its sensitivity, speed, selectivity and
ability to simultaneously measure several species present in
a mixture are clearly advantageous in comparison with
traditional structural biology methods such as NMR
spectroscopy or X-ray crystallography (26,32). An impor-
tant requisite for obtaining meaningful results by native MS
is high sample quality, such as the absence of non-volatile
buffers or salts in the spraying solution (23,25,27). There-
fore, method development is essential to answer any
particular question to be addressed by native MS. This is
particularly true when heterogeneous mixtures of aggre-
gates proteins are to be analyzed, as aimed in the present
study.
The coupling of chromatographic separation tech-
niques such as HP-SEC directly to ESI-TOF MS for the
analysis of antibody monomers has been previously
reported (33). As for IgG aggregates, Remmele et al. (18)
and Van Buren et al. (11) used ESI-MS on IgG dimers that
were enzymatically digested after chromatographic sepa-
ration. However, to our knowledge, we are the first group
combining HP-SEC with native MS for the detection of
intact monoclonal antibody aggregates. In this paper, we
present a protocol to identify intact IgG oligomers
(dimers, trimers, and tetramers), induced by pH stress on
a monomeric monoclonal IgG1 (IgG), using native ESI-
TOF MS. We analyzed and fractionated the aggregates by
HP-SEC, dialyzed the isolated fractions to aqueous
ammonium acetate and then analyzed them by ESI-
TOF MS. We demonstrate that native ESI-TOF MS
makes it possible to characterize IgG dimers, trimers and
tetramers.
MATERIALS AND METHODS
Protein and Other Materials
A monoclonal human antibody of the IgG1 subclass (IgG),
kindly provided by Biogen (Cambridge, MA USA), was
formulated at 65 mg/ml in 10 mM sodium citrate buffer
containing 5% sucrose, pH 6.0. It was diluted in a same
formulation buffer containing 10 mM sodium citrate with
5% sucrose, pH 6.0. 150 mM ammonium acetate (puriss
p.a., for mass spectrometry, Fluka, Sigma-Aldrich
Steinheim, Germany) was used as the buffer solution for
mass spectrometric analysis. The formulations were filtered
using 0.22 μm PES (polyethersulfone) low binding syringe-
driven filter units (MillexTM GP, Millipore, Ireland).
Sodium citrate dihydrate and glycine were from
Merck (Merck KGaA, Darmstadt, Germany), NaH2PO4
dihydrate, Na2HPO4 dihydrate, tris(hydroxymethyl)ami-
nomethane (Tris), β-mercaptoethanol and hydrochloric
acid (HCl) were from Sigma (Sigma, Sigma-Aldrich
Steinheim, Germany), sodium hydroxide from Boom
(Boom BV. Meppel, The Netherlands), glycerol and
sodium dodecyl sulfate (SDS) from Merck (Merck
Darmstadt and Merck, Hohenbrunn, Germany), cesium
iodide and sodium azide from Fluka (Fluka, Sigma-
Aldrich Steinheim, Germany), bromophenol blue from
Bio-Rad (Bio-Rad Hercules, USA) and 5% polyacryl-
amide tris-HCl ready gel, pre-stained broad range molec-
ular weight markers, silver stain kit from Bio-Rad (Bio-Rad
Veenendaal, The Netherlands).
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Amicon 10 kDa molecular-weight cut-off filters were
purchased from Millipore (Millipore SA, Molsheim,
France). Deionized water was obtained from a MilliQ
water purification system (Millipore, USA).
Preparation of Protein Aggregates
The sample under investigation was prepared by diluting
the monoclonal antibody formulation with the 10 mM
sodium citrate buffer containing 5% sucrose, pH 6.0 to a
final concentration of 1 mg/ml IgG. To apply the pH
stress, 1 M HCl was slowly added drop-wise with a pipette
to the antibody solution to change the pH from 6.0 to 1.0.
Then, 1 M NaOH was added to adjust the pH to 10.0.
Finally, 1 M HCl was added again to adjust the pH back to
6.0. There was approximately 1 min waiting time between
the pH shifts, while constant stirring at 500 rpm. No
precipitation was observed after the pH stress treatments.
High Performance Size Exclusion Chromatography
(HP-SEC)
Unstressed and pH-stressed samples were analyzed with
HP-SEC for the detection and separation of IgG oligomers.
For this purpose, we used a TSK Gel 3000 SWXL column
(300×7.8 mm, 5.0 μm particle size) with a TSK Gel 3000
pre-column (TOSOH Bioscience, Stuttgart, Germany)
combined with a Thermo UV detector and a Gilson 234
Autoinjector. The separation was performed at a flow rate
of 0.5 mL/min, and 300 μL of sample was injected. The
elution buffer was composed of 100 mM sodium phosphate,
100 mM sodium sulfate, 0.05% (w/v) sodium azide at pH
7.2. The elution buffer was freshly prepared, filtered and
degassed prior to use. Elution was monitored by UV
detection (280 nm). Monomer, dimer, trimer/tetramer and
high molecular weight oligomer fractions were collected in
separate vials after UV detection.
Native Mass Spectrometry
All samples were dialyzed against 150 mM ammonium
acetate at pH 6.0 using 10-kDa molecular-weight cut-off
Slide-A-Lyzer dialysis cassettes (Thermo Fisher Scientific,
Pierce Biotechnology, Rockford, USA). The dimer and
trimer/tetramer solutions were further washed with
150 mM ammonium acetate buffer solution pH 6.0, using
Amicon ultracentrifuge filters (10 kDa) prior to MS
analysis. The sample was centrifuged at 14.000 x g for
15 min at 4°C. The same devices were used to finally
concentrate the protein to about 5 mg/ml.
The obtained protein samples were measured with a
modified Waters Micromass nano-ESI-TOF MS (positive
ion mode). Needles were made from borosilicate glass
capillaries (Kwik-Fil, World Precision Instruments, USA)
on a P-97 puller (Sutter Instruments, USA), coated with a
thin gold layer by using an Edwards Scancoat six Pirani
501 sputter coater (Edwards Laboratories, USA). To
produce intact gas phase ions, the source was operated at
an elevated pressure (~7 mbar). The created droplet size
was 1 μm. The typical spray concentration of the proteins
was 5 μM and the injected volume 2 μl. Mass spectra were
recorded with a capillary voltage of 1.2 kV and a cone
voltage of 150 V. The pressure in the time-of-flight was
2.7×10-6 mbar. All spectra were calibrated using 25 mg/ml
cesium iodide solution. Further details can be found
elsewhere (34).
SDS-PAGE
Approximately 24 μg of unstressed and pH-stressed IgG
and about 3 μg of dimer (fraction 2) and high-molecular-
weight oligomers (fraction 4) collected from HP-SEC were
mixed with either non-reducing or reducing denaturing
sample buffer at a 1:4 volume ratio in 0.5 ml reaction vials
(Eppendorf, Hamburg, Germany). The non-reducing sam-
ple buffer contained 0.06 M tris(hydroxymethyl)amino-
methane (Tris), 25% (v/v) glycerol, 2% (w/v) sodium
dodecyl sulfate (SDS) and 0.1% (w/v) bromophenol blue,
and the reducing sample buffer also contained 0.7 M β-
mercaptoethanol. The samples were treated for 2 min at
98°C in an Eppendorf Thermomixer Confort (Hamburg,
Germany) and loaded in a 5% polyacrylamide tris-HCl
ready gel, alongside with pre-stained broad range molecu-
lar weight markers.
Gel electrophoresis was performed in a Bio-Rad Mini-
PROTEAN 3 cell equipped with a Bio-Rad PowerPac 300
power supply (Bio-Rad, Veenendaal, The Netherlands).
The electrophoresis buffer containing 0.3% (w/v) Tris,
1.44% (w/v) glycine and 0.1% SDS, pH 8.3. Separation
was performed at a constant current of 100 V and at
maximally 50 mA for about 1 hour. The gel was stained
using the Bio-Rad silver stain kit.
RESULTS AND DISCUSSION
HP-SEC Analysis of IgG Oligomers
IgG aggregates were prepared according to the procedure
described in the “Materials and Methods” section. We
initially compared unstressed IgG and pH-stressed IgG in
formulation buffer (citrate buffer) with HP-SEC. As can
be seen from the chromatograms in Fig. 1, it is evident that
an applied pH stress on an IgG sample results in the
formation of a number of additional peaks that are
attributed to soluble IgG aggregates. The unstressed IgG
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was predominantly monomeric (peak at 17.7 min), with a
minor peak at 14.8 min (Fig. 1, red line), whereas pH-
stressed IgG was shown to contain substantial amounts of
soluble aggregates (Fig. 1, black line), having distinct peaks
at 15.1, and 14.0, 13.2 and 12.1 min. Presumably, these
peaks belong to the dimer, trimer, tetramer and high-
molecular-weight (HMW) oligomers of IgG, respectively.
The observed slight shifts in retention times of unstressed
and pH-stressed IgG monomers and dimers are indicative
of different interactions with the column material, perhaps
due to partial unfolding and increased hydrophobicity of
these species.
Mass Spectrometric Analysis of IgG Oligomers
While HP-SEC is ideal for initial screening of IgG
oligomers, MS is far more suitable for accurate molecular
weight determinations. ESI-MS produces multiply charged
protein ions, resulting in a charge state distribution in the
spectrum. From this distribution, the molecular weight of
the protein can be determined using computer algorithms
for the deconvolution of the charge envelope. However,
ESI-MS sets stringent constraints on the sample buffer.
Most buffer solutions used in structural biology and
pharmaceutical formulations are not compatible with ESI-
MS. The sample solution for ESI-MS needs to be free of
any interfering charged species, such as salts and metal ions,
as they may obstruct the protein ionization process (27,35).
For this purpose, aqueous ammonium acetate solution has
been introduced previously as an ESI-MS–compatible
‘volatile buffer.’ This volatile buffer easily desolvates,
evaporation of solvents leading to the formation of gas-
phased ions of protein molecules, and in the meantime the
original quaternary structure of the protein is usually
preserved (26,27).
Among many other approaches to identify the proteins
by MS, we have followed a “top-down” method for the
identification of intact protein aggregates (36). In this
approach, the protein sample, dissolved in aqueous ammo-
nium acetate buffer, is directly injected to ESI-TOF MS
instrument without any chemical or enzymatic treatment.
This results in a molecular mass of the intact protein and/
or protein aggregates and their major post-translational
modifications.
Fig. 1 Size-exclusion chromatograms of unstressed IgG (red) vs. pH-
stressed IgG (black) in 10 mM citrate buffer pH 6.0.
Fig. 2 ESI-TOF MS spectra of
unstressed (top) and pH-stressed
(bottom) IgG solutions, without
HP-SEC separation. Samples are
in 150 mM ammonium acetate
buffer pH 6.0.
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Figure 2 shows the mass spectra of unstressed IgG (top)
and pH-stressed IgG (bottom). These spectra represent
characteristic charge envelopes belonging to the protein
species. Peaks distributed between m/z 5000 to 7000
represent the different charged states of monomeric IgG,
both in unstressed and pH-stressed samples. At first glance
the spectra are very similar. Detailed analysis, however,
shows that the spectrum of unstressed IgG contains 99.8%
monomer and 0.2% dimer (top panel, zoomed inset),
whereas that of pH-stressed IgG shows 90.1% monomer,
9.5% dimer, and 0.4% trimer (Fig. 2, lower panel, zoomed
inset). These percentages were calculated using the peak
intensities of the entire charge state distribution for all
species present.
Mass Spectrometric Analysis of HP-SEC Fractions
As can be seen in the previous section, the monomer signal is
very abundant in pH-stressed IgG solution, and it suppresses
the MS signals deriving from the other (higher oligomer)
species in the solution. However, HP-SEC clearly showed
the existence of other species. Therefore, chromatographic
Fig. 3 Size-exclusion chromatograms of collected fractions of pH-
stressed IgG; HMW: High-molecular-weight aggregates (black), trimers/
tetramers (red), dimers (green) and monomer (blue). Spectra are not
normalized.
Fig. 4 Deconvoluted ESI-TOF
MS of pH-stressed IgG fractions.
Spectra are belonging to HP-SEC
fractions 1 (top), fraction 2
(middle), and fraction 3 (bottom).
The corresponding approximate
molecular weights are depicted
next to the peaks.
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separation and purification of the individual fractions was
performed. In this way, we can isolate and individually study
the structural information and possible conformational
variants within the dimers, trimers, and other oligomers.
HP-SEC was used to isolate the monomer, dimer,
trimer/tetramer and HMW oligomer fractions of the
stressed IgG mixture. The stability and purity of these
fractions were tested by re-analyzing them with the same
HP-SEC method (Fig. 3). Clearly, isolation of the individ-
ual species was successful: four fractions presumably
corresponding to monomer, dimer, trimer/tetramer and
HMW oligomers were obtained. The trimer and tetramer
species were collected simultaneously because of the
difficulty in separating the two species with this HP-SEC
column. In addition, the results show that the separated
products are largely irreversible as analysis of the individual
fractions hardly shows other oligomeric forms or mono-
meric IgG in their respective chromatograms (Fig. 3).
Unfortunately, mobile phases containing volatile salts,
tested for HP-SEC coupled with MS analysis of a recombi-
nant IgG product were shown to be poor in terms of
chromatographic separation and mass spectrometric perfor-
mance (37). Similarly, prior to MS analysis, we dialyzed the
oligomer fractions isolated by HP-SEC against an aqueous
ammonium acetate solution as in the case of non-fractioned
samples. Re-analysis of the dialyzed samples by HP-SEC
indicated that the oligomeric state of the different fractions
was not measurably affected (data not shown).
Figure 4 shows the deconvoluted MS spectra of the HP-
SEC fractions containing intact IgG monomer, dimers and
trimers/tetramers. Deconvolution of their charge envelopes
resulted in mass values of 147,339±101 Da for the
monomer, 294,709±93 Da for the dimer, 441,950±
313 Da for the trimer and 589,745 ±228 Da for the
tetramer. We were not able to obtain good signals for
fraction 4.
Fig. 6 Silver-stained SDS-PAGE gel run under nonreducing (NR) and
reducing (R) conditions. Lanes belong to standards (1), unstressed IgG (2
for NR, 6 for R), pH-stressed IgG (3 for NR, 7 for R), HP-SEC fraction 2
(4 for NR, 8 for R) and HP-SEC fraction 4 (5 for NR, 9 for R) of pH-
stressed IgG (see Fig. 3 for HP-SEC profiles of the fractions).
Fig. 5 Bars representing the
summed intensities for all IgG
species observed in each fraction.
For illustration, the raw MS
spectra used to calculate the
relative abundances are depicted
above.
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In Fig. 5, we compare the relative abundances of the
species in each fraction. In addition to the expected
oligomeric state, other species were detected as well.
There was a trace amount of dimer (0.5%) present in the
fraction 1, whereas the MS spectrum of the fraction 2
showed ~15% monomer and 2% trimer. The MS
spectrum of the fraction 3 consisted of 57% trimer, 17%
tetramer, 13% dimer and 13% monomer IgG. Similar
calculations on the HP-SEC results depicted in Fig. 3 show
that the fraction 1 contained ~0.3% dimer, which is in
good agreement with the MS estimations. On the other
hand, the percentages of monomer and oligomers in
fractions 2 and 3, as calculated from HP-SEC and MS,
differed considerably. For instance, fraction 2 contained
only 0.6% monomer according to HP-SEC, whereas in
MS, 15% monomer was found. The discrepancies be-
tween the MS and HP-SEC results are likely due to
intrinsic differences between the two separation techni-
ques. Moreover, note that MS, unlike HP-SEC, is not
considered to yield quantitative results.
SDS-PAGE
SDS-PAGE is a well-established technique to investigate
whether the aggregates formed were composed of cova-
lently and/or non-covalently linked species (4,38).
In the literature, the simultaneous formation of covalent
and non-covalent dimers has been reported for different
IgG mAbs (18,39–41). In addition, it has been observed
that some short-term stressed non-covalent antibody dimers
can irreversibly convert into covalent dimers (18,42). The
amount of non-covalent and covalent dimers formed by
several IgG species depended on IgG type, solution
conditions, and temperature (11).
We performed non-reducing and reducing SDS-PAGE
on the unstressed IgG, pH-stressed IgG, isolated fraction 2
and fraction 4, as depicted in Fig. 6. Given that the amount
of dimer was less abundant compared to monomer in both
unstressed and pH-stressed IgG according to HP-SEC, an
excessive amount of these samples was loaded in the slots of
the gel in order to detect these dimers. This resulted in
over-exposure of the monomer band at ~150 kDa in lanes
2 and 3 (Fig. 6), while the dimer bands were visible at
~300 kDa. In fact, the dimer bands under non-reducing
conditions are rather similar in intensity between these two
samples, which indicates that the majority of dimers were
non-covalently linked. This was confirmed by SDS-PAGE
analysis of the dimer fraction (Fig. 6, lane 4), where most of
the dimers collected by HP-SEC fractionation had
dissociated into monomers under denaturing conditions.
For the HMW oligomer fraction 4, a band can be
observed at the top of lane 5 and another one at
~150 kDa, which means that this fraction contained both
covalent and non-covalent oligomers. The lack of any
HMW bands on the gel run under reducing conditions
(Fig. 6, lane 9) indicates that these covalent aggregates
were disulfide mediated. Nevertheless, the pH-stressed
IgG dimers were strong enough to remain intact during
HP-SEC analysis, dialysis, and subsequent ESI-TOF MS
analysis.
CONCLUSION
In this paper, we have combined chromatographic separation
of protein oligomers with intact protein characterization by
native ESI-TOF MS. We have described a HP-SEC/buffer
exchange protocol that enables native ESI-TOF MS analysis
of pH-stressed IgG samples. We have shown that proper
sample preparation and chromatographic separation of
monomer, dimer and trimer/tetramer fractions by HP-SEC
have resulted in improved MS analysis, as compared to MS
analysis prior to HP-SEC separation. Both the sample
preparation and the native ESI-TOF MS technique leave
the aggregates intact. In conclusion, ESI-TOF MS is a useful
method that adds to our current analytical arsenal to identify
and characterize mAb oligomers.
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